Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Mar-19 8:58 PM View:  | Revance Therapeutics, Inc. (RVNC) | 18-Mar-19 | Market Sale (Planned) | 498 | $15.48 | $7,709.04 | (7%) 6.9K to 6.4K | (78%) |
| 19-Mar-19 8:58 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Mar-19 | Payment of Exercise | 252 | $15.45 | $3,893.40 | (4%) 7.15K to 6.9K | (79%) |
| 25-Jan-19 8:51 PM View: | Revance Therapeutics, Inc. (RVNC) | 24-Jan-19 | Grant | 3,150 | -- | -- | 79% 4.0K to 7.15K | |
| 23-Jan-19 9:38 PM View: | Revance Therapeutics, Inc. (RVNC) | 22-Jan-19 | Option Exercise | 625 | $13.35 | $8,343.75 | 16% 4.0K to 4.63K | |
| 23-Jan-19 9:38 PM View: | Revance Therapeutics, Inc. (RVNC) | 22-Jan-19 | Market Option Sale (Planned) | 625 | $17.77 | $11,106.20 | (14%) 4.63K to 4.0K | (55%) |
| 04-Jan-19 9:33 PM View: | Revance Therapeutics, Inc. (RVNC) | 03-Jan-19 | Market Sale (Planned) | 375 | $19.48 | $7,305.00 | (9%) 4.38K to 4.0K | (42%) |
| 02-Jan-19 8:02 PM View: | Revance Therapeutics, Inc. (RVNC) | 31-Dec-18 | Acquisition (other) | 375 | $17.11 | $6,416.44 | 9% 4.0K to 4.38K | |
| 21-Nov-18 6:30 PM View: | Revance Therapeutics, Inc. (RVNC) | 20-Nov-18 | Market Sale (Planned) | 491 | $20.66 | $10,144.10 | (11%) 4.49K to 4.0K | (34%) |
| 16-Nov-18 6:17 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Nov-18 | Payment of Exercise | 259 | $20.99 | $5,436.41 | (5%) 4.75K to 4.49K | (31%) |
| 09-Nov-18 8:59 PM View: | Revance Therapeutics, Inc. (RVNC) | 09-Nov-18 | Option Exercise | 2,188 | $13.35 | $29,209.80 | 46% 4.75K to 6.94K | |
| 09-Nov-18 8:59 PM View: | Revance Therapeutics, Inc. (RVNC) | 09-Nov-18 | Market Option Sale (Planned) | 2,188 | $23.72 | $51,899.40 | (32%) 6.94K to 4.75K | (16%) |
| 06-Jul-18 9:17 PM View: | Revance Therapeutics, Inc. (RVNC) | 06-Jul-18 | Market Sale (Planned) | 393 | $28.35 | $11,141.50 | (8%) 5.14K to 4.75K | 3% |
| 03-Jul-18 8:20 PM View: | Revance Therapeutics, Inc. (RVNC) | 29-Jun-18 | Acquisition (other) | 393 | $23.33 | $9,169.67 | 8% 4.75K to 5.14K | |
| 22-Jun-18 8:58 PM View: | Revance Therapeutics, Inc. (RVNC) | 20-Jun-18 | Grant | 250 | -- | -- | 6% 4.5K to 4.75K |